| PERIOD ENDING | 28-Feb-09 | 28-Feb-08 | 28-Feb-07 | | Total Revenue | 98,370 | 140,907 | 222,339 | | Cost of Revenue | 60,244 | 122,412 | 172,938 | | | Gross Profit | 38,126 | 18,495 | 49,401 | | | Operating Expenses | | Research Development | 12,899 | 15,710 | 15,015 | | Selling General and Administrative | 21,046 | 25,599 | 22,534 | | Non Recurring | 44,736 | 71,586 | 36,698 | | Others | 4,429 | 6,418 | 4,135 | | | | Total Operating Expenses | 83,110 | 119,313 | 78,382 | | | | Operating Income or Loss | (44,984) | (100,818) | (28,981) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 180 | (569) | 1,034 | | Earnings Before Interest And Taxes | (44,804) | (101,387) | (27,947) | | Interest Expense | 1,091 | 1,903 | 460 | | Income Before Tax | (45,895) | (103,290) | (28,407) | | Income Tax Expense | 3,770 | (20,940) | 2,781 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (49,665) | (82,350) | (31,188) | | | Non-recurring Events | | Discontinued Operations |
-
| (1,799) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (49,665) | (84,149) | (31,188) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($49,665) | ($84,149) | ($31,188) |
|
0.22% Nasdaq 
Income Statement
